Distalmotion has closed a Series G funding round totalling $150m to expedite the expansion of its soft tissue robotic surgery system, DEXTER, in the US. The funds will also be directed to support product and clinical development efforts that are currently underway. The round was spearheaded by Revival Healthcare Capital, with participation from inside investors. A central aspect of Distalmotion’s strategy is to target the Ambulatory Surgery Center (ASC) segment in the US. DEXTER has already been in cli ...